Your browser doesn't support javascript.
loading
Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients.
de Vrij, Nicky; Pollmann, Julia; Rezende, Antonio M; Ibarra-Meneses, Ana V; Pham, Thao-Thy; Hailemichael, Wasihun; Kassa, Mekibib; Bogale, Tadfe; Melkamu, Roma; Yeshanew, Arega; Mohammed, Rezika; Diro, Ermias; Maes, Ilse; Domagalska, Malgorzata A; Landuyt, Hanne; Vogt, Florian; van Henten, Saskia; Laukens, Kris; Cuypers, Bart; Meysman, Pieter; Beyene, Hailemariam; Sisay, Kasaye; Kibret, Aderajew; Mersha, Dagnew; Ritmeijer, Koert; van Griensven, Johan; Adriaensen, Wim.
Afiliação
  • de Vrij N; Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Pollmann J; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020, Antwerp, Belgium.
  • Rezende AM; Department of Medical Oncology, University Hospital Heidelberg, National Center for Tumor Diseases (NCT) Heidelberg, 69120, Heidelberg, Germany.
  • Ibarra-Meneses AV; Department of Microbiology, Aggeu Magalhães Institute-FIOCRUZ/PE, Recife, Brazil.
  • Pham TT; Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.
  • Hailemichael W; Clinical Immunology Unit, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Kassa M; Department of Immunology and Molecular Biology, Faculty of Biomedical Sciences, University of Gondar, Gondar, Ethiopia.
  • Bogale T; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Melkamu R; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Yeshanew A; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Mohammed R; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Diro E; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Maes I; Leishmaniasis Research and Treatment Centre, University of Gondar, Gondar, Ethiopia.
  • Domagalska MA; Molecular Parasitology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Landuyt H; Molecular Parasitology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Vogt F; Clinical Trial Unit, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • van Henten S; National Centre for Epidemiology and Population Health, The Australian National University, Canberra, 2601, Australia.
  • Laukens K; The Kirby Institute, University of New South Wales, Sydney, 2052, Australia.
  • Cuypers B; Unit of Neglected Tropical Diseases, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Meysman P; Unit of Neglected Tropical Diseases, Department of Clinical Sciences, Institute of Tropical Medicine, 2000, Antwerp, Belgium.
  • Beyene H; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020, Antwerp, Belgium.
  • Sisay K; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020, Antwerp, Belgium.
  • Kibret A; Adrem Data Lab, Department of Computer Science, University of Antwerp, 2020, Antwerp, Belgium.
  • Mersha D; Médecins Sans Frontières, Abdurafi, Ethiopia.
  • Ritmeijer K; Médecins Sans Frontières, Abdurafi, Ethiopia.
  • van Griensven J; Médecins Sans Frontières, Abdurafi, Ethiopia.
  • Adriaensen W; Médecins Sans Frontières, Abdurafi, Ethiopia.
Commun Biol ; 7(1): 524, 2024 May 03.
Article em En | MEDLINE | ID: mdl-38702419
ABSTRACT
A large proportion of HIV-coinfected visceral leishmaniasis (VL-HIV) patients exhibit chronic disease with frequent VL recurrence. However, knowledge on immunological determinants underlying the disease course is scarce. We longitudinally profiled the circulatory cellular immunity of an Ethiopian HIV cohort that included VL developers. We show that chronic VL-HIV patients exhibit high and persistent levels of TIGIT and PD-1 on CD8+/CD8- T cells, in addition to a lower frequency of IFN-γ+ TIGIT- CD8+/CD8- T cells, suggestive of impaired T cell functionality. At single T cell transcriptome and clonal resolution, the patients show CD4+ T cell anergy, characterised by a lack of T cell activation and lymphoproliferative response. These findings suggest that PD-1 and TIGIT play a pivotal role in VL-HIV chronicity, and may be further explored for patient risk stratification. Our findings provide a strong rationale for adjunctive immunotherapy for the treatment of chronic VL-HIV patients to break the recurrent disease cycle.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Coinfecção / Leishmaniose Visceral Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Commun Biol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Coinfecção / Leishmaniose Visceral Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Africa Idioma: En Revista: Commun Biol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica